Mbx Biosciences Inc (MBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -61,922 | -32,563 | -26,135 |
| Depreciation Amortization | 244 | 157 | 56 |
| Accounts payable and accrued liabilities | 7,098 | 457 | 2,123 |
| Other Working Capital | 4,597 | -735 | 1,290 |
| Other Operating Activity | -4,698 | 706 | -456 |
| Operating Cash Flow | $-54,681 | $-31,978 | $-23,122 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -159,721 | -30,798 | -10,970 |
| PPE Investments | -874 | -129 | -441 |
| Investing Cash Flow | $-160,595 | $-30,927 | $-11,411 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | N/A | 10,000 |
| Common Stock Issued | 174,945 | 739 | 30 |
| Other Financing Activity | 59,159 | 68,479 | 36,033 |
| Financing Cash Flow | $234,104 | $69,218 | $46,063 |
| Beginning Cash Position | 30,523 | 24,210 | 12,680 |
| End Cash Position | 49,351 | 30,523 | 24,210 |
| Net Cash Flow | $18,828 | $6,313 | $11,530 |
| Free Cash Flow | |||
| Operating Cash Flow | -54,681 | -31,978 | -23,122 |
| Capital Expenditure | -874 | -129 | -441 |
| Free Cash Flow | -55,555 | -32,107 | -23,563 |